Coagulation Conference

 

Conference Overview

Wednesday-Friday, August 4-6, 2010

This 14th Mayo coagulation conference will provide reviews and updates about laboratory and clinical aspects of bleeding and thrombosing disorders. Didactic presentations will be supplemented with panel discussions and case presentations. Adequate time will be allocated for questions. 

Learning Objectives

Upon completion of the conference participants should be able to:

• Describe recommended clinical and laboratory evaluation for von Willebrand disease (VWD)
• Assess common acquired disorders of plasmatic hemostasis that lead to bleeding or thrombosis
• Recognize features of hereditary platelet disorders
• Evaluate antibody-mediated prothrombotic disorders such as heparin-induced thrombocytopenia, thrombotic thrombocytopenic purpura, or lupus anticoagulant and antiphospholipid syndrome
• Summarize clinical features and laboratory evaluation of congenital and acquired hemophilias
• Discuss acquired thrombophilic disorders, congenital antithrombin deficiency, utilization of D-dimer testing results for evaluation of venous thromboembolism, and features of newer anticoagulant drugs

Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.

Intended Audience

This program is designed for clinicians, pathologists, scientists, and laboratory technologists whose practices include bleeding and thrombosing diseases.